Health-tech company Masimo, best known for its successful patent litigation over the Apple Watch, is facing a proxy fight for the second time in two years — from the same activist investor who now ...
Masimo (NASDAQ: MASI) today hosted its 2025 Investor Day at the Company’s headquarters. At the event, Masimo’s management team provided an update on the Company’s long-term strategy, including the ...
Ahead of the formal report scheduled for February 26, 2026, Masimo has released key preliminary data for the final quarter of 2025. Revenue is estimated at approximately $411 million, representing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results